CING
Price
$5.03
Change
-$0.11 (-2.14%)
Updated
Sep 27 closing price
KZIA
Price
$0.39
Change
+$0.03 (+8.33%)
Updated
Sep 27 closing price
Ad is loading...

CING vs KZIA

Header iconCING vs KZIA Comparison
Open Charts CING vs KZIABanner chart's image
Cingulate
Price$5.03
Change-$0.11 (-2.14%)
Volume$116.28K
CapitalizationN/A
Kazia Therapeutics
Price$0.39
Change+$0.03 (+8.33%)
Volume$823.25K
CapitalizationN/A
View a ticker or compare two or three
CING vs KZIA Comparison Chart
Loading...
CING
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CING vs. KZIA commentary
Sep 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CING is a StrongSell and KZIA is a Hold.

COMPARISON
Comparison
Sep 29, 2024
Stock price -- (CING: $7.00 vs. KZIA: $0.38)
Brand notoriety: CING and KZIA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CING: 11% vs. KZIA: 4%
Market capitalization -- CING: $10.96M vs. KZIA: $13.12M
CING [@Biotechnology] is valued at $10.96M. KZIA’s [@Biotechnology] market capitalization is $13.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.37B to $0. The average market capitalization across the [@Biotechnology] industry is $3.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CING’s FA Score shows that 0 FA rating(s) are green whileKZIA’s FA Score has 0 green FA rating(s).

  • CING’s FA Score: 0 green, 5 red.
  • KZIA’s FA Score: 0 green, 5 red.
According to our system of comparison, CING is a better buy in the long-term than KZIA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CING’s TA Score shows that 5 TA indicator(s) are bullish while KZIA’s TA Score has 3 bullish TA indicator(s).

  • CING’s TA Score: 5 bullish, 4 bearish.
  • KZIA’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, KZIA is a better buy in the short-term than CING.

Price Growth

CING (@Biotechnology) experienced а -29.15% price change this week, while KZIA (@Biotechnology) price change was -13.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.80%. For the same industry, the average monthly price growth was +5.34%, and the average quarterly price growth was -8.06%.

Reported Earning Dates

CING is expected to report earnings on Mar 08, 2024.

Industries' Descriptions

@Biotechnology (+3.80% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KZIA($13.1M) has a higher market cap than CING($11M). KZIA YTD gains are higher at: -13.902 vs. CING (-92.375).
CINGKZIACING / KZIA
Capitalization11M13.1M84%
EBITDAN/AN/A-
Gain YTD-92.375-13.902664%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt423KN/A-
FUNDAMENTALS RATINGS
KZIA: Fundamental Ratings
KZIA
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CINGKZIA
RSI
ODDS (%)
Bearish Trend about 1 month ago
0%
N/A
Stochastic
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Momentum
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
MACD
ODDS (%)
Bullish Trend about 1 month ago
0%
N/A
TrendWeek
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
TrendMonth
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Advances
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Declines
ODDS (%)
Bearish Trend about 2 months ago
90%
Bearish Trend about 2 months ago
0%
BollingerBands
ODDS (%)
Bearish Trend about 1 month ago
0%
N/A
Aroon
ODDS (%)
Bearish Trend about 1 month ago
0%
N/A
View a ticker or compare two or three
Ad is loading...
CING
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KZIA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

CING and

Correlation & Price change

A.I.dvisor tells us that CING and GOVX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CING and GOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
-11.28%
GOVX - CING
31%
Poorly correlated
-2.38%
CYTK - CING
25%
Poorly correlated
-4.41%
ACST - CING
22%
Poorly correlated
-2.48%
ELTX - CING
22%
Poorly correlated
+1.84%
VOR - CING
22%
Poorly correlated
-4.68%
More

KZIA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KZIA has been closely correlated with HOOK. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if KZIA jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZIA
1D Price
Change %
KZIA100%
-10.61%
HOOK - KZIA
73%
Closely correlated
-2.49%
FRES - KZIA
61%
Loosely correlated
-2.01%
QURE - KZIA
28%
Poorly correlated
-4.79%
CING - KZIA
27%
Poorly correlated
-11.28%
SRPT - KZIA
26%
Poorly correlated
-0.50%
More